Home Current issue Archives Editorial staff For Authors For Reviewers For Sponsors Contact

Information for authors

Asthma Immunology – clinical review. The original papers are peer-reviewed. Usually editorial staff choose two readers who review papers during two weeks. Then the manuscript with review is sent to authors and after beeing corrected is delivered to Editorial Office to final acceptation. However, all review articles are accepted by Editor-in-Chief after taking advice of Editorial Board. A complete manuscript should be sent via e-mail on the following e-mail address: mediton2@mediton.pl. The editor reserves the right to alter and correct the manuscript considered for publication in a way that will not change its overall value. Manuscripts that do not meet these requirements will be returned to authors for correction. With the manuscript the authors submit a declaration signed by all authors of the paper: „We confirm the original form of the paper. The copyright or any other rights of property of the third party are not violated nor the paper has previously been published or submitted elsewhere. We also declare that we do not work up on animals.” After publishing the paper, the authors transfer the copyright to MEDITON Publisher. Additionally, the manuscript of a case-report must include the clause: „We declare that during research there were all patient’s principles observed due to Helsinki Convention”. In the case of reprints from other journals the authors are obliged to warrant permission from respective editors.
Counteracting author’s rights violation.
In order to counteract ghostwriting and guest authorship the Editorial Office requires that all authors of a given article disclose their affiliations, and their real contribution in the article preparation. Otherwise the article will not be published. In this aspect it is the author who submits the article that is considered to bear the principal responsibility.
Financial disclosure
The authors of sponsored articles are obliged to disclose the sources of funding (the financial disclosure statement is published with the article).
Statement of conflict of interest
All authors submitting an article to the Journal should individually declare any conflict of interest related to the publication.
Manuscript
Manuscript in both Polish and English should be prepared in an electronic form. The manuscript of a review article, including tables (max. 3) and figures (max. 3) should not exceed 18 pages of a standard type (about 260 words per page). The manuscript of an original article – 12 pages of a standard type, including tables (max. 3) and figures (max. 3), and of a case report – 9 pages of a standard type, including max. 1 table and 1 figure. The number of references: review article – 60, original article – 30, case report – 10.
Title of the paper
in Polish and English should be concise, it should not exceed 120 characters. A subtitle is acceptable. The title is to be followed by the names of authors, including their first names, and affiliations. Main author and address for correspondence should be provided. It is indeed necessary to follow the guidelines on the title length.
Summary
should be prepared in Polish and English and should not exceed 250 words. It must be structured within introduction, aim, material and methods, results and conclusion parts.
Keywords
provided in both Polish and English should not exceed 7 in number.
The paper
itself should be written in a concise and clear way; neither medical nor scientific slang words or phrases can be accepted. The text of original papers should be divided into the following sections: materials and methods, results and discussion. Latin words, such as the names of microorganisms, and other foreign words should be writted in italics.
Abbreviations, symbols and units
Only common abbreviations may be left unexplained. Less known abbreviations and symbols must be explained when used for the first time in the manuscript. No abbreviations are acceptable in the title. SI units are recommended; however, also other generally used units (l, min., h, C, Da, cal) are accepted.
Figures (drawings, photographs)
should be numbered. Figure captions should be printed on a separate page. If figures are taken from published sources, the author must get appropriate editor’s approval to publish them. Acknowledgment should be given at the end of the caption for such a figure. Color figures can be included for publication, however, in each case this should be agreed with the Editor. Drawings should be prepared using tools available in word processors, in Excel or specialist editors e.g. CorelDraw. Figures drawn professionally in black India ink on white paper are also acceptable. Photographs must be of high quality.
Tables
should be on separate sheets, numbered consecutively and headed by a concise title. Put explanatory matter in footnotes. Tables are adjuncts to the text and should not repeat material presented therein.
References
should be quoted subsequently in the text in square brackets [1,2]. Unpublished data can be referred to providing the source of information in brackets in the text. Each reference should include: Author’s name and initial(s). Title. Abbreviated title of journal. Year; Volume: pages.
Examples: 1. Szmidt A, Stańczyk-Przyłuska A. Rola wirusa EBV w patogenezie chorób alergicznych. Alergia Astma Immunologia 2005; 4: 169-174. 2. Smith E, Gray SD et al. Frequency and effects of teachers’ voice problems. J Voice 1997; 11: 81-87. Book should be quoted as follows: Author’s name and initial(s). Title of chapter. (in) Book title. Name and initial(s) (Ed.). Publisher, Place of publication Year: pages. Examples: 1. Kieć-Świerczyńska M. Alergia kontaktowa. Mediton, Łodź 2005: 43-55. 2. Bieńkiewicz B, Kowalski ML. Alergia na leki. (w) Immunologia kliniczna. Kowalski ML (red.) Mediton, Łodź 2000: 297-328.
Reprints
Reprints of published papers (ten copies) are provided to authors free of charge at the indicated address for correspondence.

Author's Declaration (.doc)



Home Current Issue Archves Editorial Staff For Authors For Reviewers For Sponsors Contact